My passion is science and its potential for improving quality of life. My goal is to see quality therapeutics developed and marketed through strategic commercialization. To achieve this, I am always searching for opportunities to build relationships with thought leaders and professionals engaged in tackling important health concerns.
鈥∕y greatest asset is experience encompassing the pre-approval stages of drug and device development, from basic research (DNAX and Duke), translational research (Duke), clinical research (Stanford and Quintiles), to commercialization (University of Miami, Novelios and Reveve Consulting). I understand what both small and large companies experience in assimil...
We鈥檝e updated our privacy policy so that we are compliant with changing global privacy regulations and to provide you with insight into the limited ways in which we use your data.
You can read the details below. By accepting, you agree to the updated privacy policy.
